Dr. John C. Rhee

Dan P. Zandberg, MD, is an associate professor of medicine and a medical oncologist/hematologist, specializing in the treatment of head and neck and thyroid cancers. He is the Director of the Head and Neck and Thyroid Cancer disease sections for the division of Hematology/Oncology and the Medical Oncology Co-Leader of the UPMC Hillman Head and Neck Cancer Program. He is also the physician lead for the second floor Hillman Cancer Center clinic. His main research focus is in the development of clinical trials with immunotherapy to improve patient outcomes. Recent awards include the 2019 National Cancer Institute (NCI) Cancer Clinical Investigator Team Leadership Award, 2020 Leo Criep, M.D. Excellence in Patient Care Award, and 2020/2021 Castle Connolly Regional Top Doctor. Dr. Zandberg is rated as a Distinguished provider by MediFind in the treatment of Adenoid Cystic Carcinoma. His top areas of expertise are Oral Squamous Cell Carcinoma, Small Cell Lung Cancer (SCLC), ALK-Positive Non-Small Cell Lung Cancer, and Squamous Cell Lung Carcinoma.

Rahim A. Remtulla, MD, FACP, is a medical oncologist at UPMC Hillman Cancer Center. Dr. Remtulla specializes in the evaluation and treatment of all generalized oncology cases, various hematologic malignancies ; including chronic leukemia, multiple myeloma, lymphomas ; and benign hematologic conditions. Dr. Remtulla is rated as an Advanced provider by MediFind in the treatment of Adenoid Cystic Carcinoma. His top areas of expertise are Pulmonary Embolism, Thrombocytopenia, Pleuropulmonary Blastoma, and Lung Cancer.

Stanley Marks, MD, specializes in hematology oncology and medical oncology and is board-certified in hematology and internal medicine by the American Board of Internal medicine. Dr. Marks completed his medical degree at the University of Pittsburgh School of Medicine. He completed his residency training at Presbyterian Hospital, and fellowship training in clinical medicine and research medicine at Peter Bent Brigham Hospital, Harvard Medical School and Dana Farber Cancer Center. He has received numerous awards including the Golden Apple Award for Outstanding Dedication to Housestaff Education from Allegheny General Hospital, Hillel Academy Outstanding Alumnus, and The Winged Victory of Samothrace Award from the Leukemia, Lymphoma Society of Western Pennsylvania. Dr. Marks is rated as a Distinguished provider by MediFind in the treatment of Adenoid Cystic Carcinoma. His top areas of expertise are Non-Hodgkin Lymphoma, Primary Lymphoma of the Brain, Gastric Lymphoma, and Follicular Lymphoma.